University of California San Francisco

Rifaximin is a small molecule antibiotic. It targets gut bacteria to reduce inflammation and potentially improve motor impairment. This approach is based on the idea that gut health may influence neurodegenerative processes, and managing harmful bacteria could slow or improve motor symptoms in Parkinson's disease.